Matt Shaulis

Matt Shaulis joined BeiGene as General Manager of North America in September 2024.

Mr. Shaulis joined from Hansa Biopharma, where he served as Chief Commercial Officer and U.S. President. Prior to joining Hansa, he was President of Pfizer Inflammation and Immunology for International Developed Markets and previously was Pfizer’s President of North America Oncology.

He joined Pfizer from Cephalon (acquired by Teva Pharmaceuticals), where he was Vice President and Global Therapeutic Area Lead, Multiple Sclerosis, with prior experience in senior sales and marketing roles with Cephalon, Johnson & Johnson and Schering-Plough.

Mr. Shaulis earned his bachelor’s degree from Penn State University and his MBA from the Fuqua School of Business at Duke University.